A possible side effect of medically induced ovulation, characterized by swollen, painful ovaries and, in some cases, the accumulation of fluid in the abdomen and chest.
A possible side effect of treatment with human menopausal gonadotropin in which the ovaries become painful and swollen and fluid may accumulate in the abdomen and chest.
A syndrome that may include ovarian enlargement, gastrointestinal symptoms, abdominal distension and weight gain. Severe cases may be further complicated with cardiovascular, pulmonary and electrolyte disturbances, requiring hospitalisation
A syndrome rarely encountered during ovulation induction. Symptoms of ovarian hyperstimulation syndrome may include ovarian enlargement, accumulation of fluid in the abdomen, gastrointestinal disorders, abdominal distension and weight gain. Severe cases may be further complicated with cardiovascular and pulmonary disturbances, requiring hospitalization.
A condition indicated by ovarian enlargement, gastrointestinal symptoms, abdominal distension and weight gain
Ovaries become swollen and painful. The woman feels bloated, nauseated and may experience vomiting. 10 percent of ovulation induction patients experience some kind of hyperstimulation syndrome.
This is a potentially serious complication associated with the use of gonadotropins, but can also happen with Clomiphene citrate. The usual clinical situation involves the development of multiple follicles with high levels of estrogen. If hCG is given to trigger ovulation, the ovaries and surrounding tissue may start weeping large amouts of fluid into the peritoneal cavity. This can result in circulatory, vascular, or respiratory difficulties in addition to the discomfort associated with enlarged ovaries. Severe hyperstimulation requires intensive in-hospital care.
